Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 36, 2022 - Issue 5
239
Views
3
CrossRef citations to date
0
Altmetric
Short Communications

Development, characterisation, stability study and antileukemic evaluation of nanoemulsions containing Astrocaryum aculeatum extract

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1321-1326 | Received 17 Jul 2020, Accepted 06 Dec 2020, Published online: 24 Dec 2020
 

Abstract

The objective of this work was to produce and characterise nanoemulsions containing tucumã extract and to evaluate the performance of the nanostructure and the free compound regarding antitumor activity, cytotoxicity, and oxidative metabolism in NB4/APL cells. The nanoemulsions showed adequate physicochemical characteristics (average size approx. 200 nm, polydispersity index less than 0.3, negative zeta potential and acid pH) maintained stable up to 90 days of storage in refrigeration condition. The nanoformulations did not present protein corona formation. Blank nanoemulsion treatments showed moderate toxicity. Furthermore, the nanoemulsion loaded with extract showed better antileukemic results than the free extract. However, nanoemulsions can be promising carriers of natural compounds, emphasising their biological properties and constituting alternatives in treating diseases.

Acknowledgments

The authors are grateful to “Coordenação de Aperfeiçoamento de Pessoal de Nível Superior” (CAPES), Franciscan University, Federal University of Santa Maria and Federal University of Pampa (Bagé).

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was performed with financial support from research agency “Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (FAPERGS)” – notice 01/2017 – ARD (17/2551-0000805-7).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.